The same researchers later added BMP-2 to the same treatment in a murine radial segmental defect infection model, whereupon they observed additional bone regeneration complementing the successful infection prophylaxis [85] However, the ability to treat established infection in vivo was not evaluated, despite the established knowledge that lysostaphin can adequately disrupt biofilms [86,87]. Here, BMP2 is linked to infection.